CADL
Price
$5.02
Change
+$0.60 (+13.57%)
Updated
Dec 3 closing price
Capitalization
275.59M
112 days until earnings call
Intraday BUY SELL Signals
OSTX
Price
$1.75
Change
+$0.09 (+5.42%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
60.22M
Intraday BUY SELL Signals
Interact to see
Advertisement

CADL vs OSTX

Header iconCADL vs OSTX Comparison
Open Charts CADL vs OSTXBanner chart's image
Candel Therapeutics
Price$5.02
Change+$0.60 (+13.57%)
Volume$1.21M
Capitalization275.59M
OS Therapies
Price$1.75
Change+$0.09 (+5.42%)
Volume$470
Capitalization60.22M
CADL vs OSTX Comparison Chart in %
CADL
Daily Signal:
Gain/Loss:
OSTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CADL vs. OSTX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CADL is a Hold and OSTX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (CADL: $4.41 vs. OSTX: $1.66)
Brand notoriety: CADL and OSTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CADL: 44% vs. OSTX: 34%
Market capitalization -- CADL: $245.94M vs. OSTX: $60.22M
CADL [@Biotechnology] is valued at $245.94M. OSTX’s [@Biotechnology] market capitalization is $60.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CADL’s FA Score shows that 0 FA rating(s) are green whileOSTX’s FA Score has 0 green FA rating(s).

  • CADL’s FA Score: 0 green, 5 red.
  • OSTX’s FA Score: 0 green, 5 red.
According to our system of comparison, OSTX is a better buy in the long-term than CADL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CADL’s TA Score shows that 6 TA indicator(s) are bullish while OSTX’s TA Score has 3 bullish TA indicator(s).

  • CADL’s TA Score: 6 bullish, 4 bearish.
  • OSTX’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, CADL is a better buy in the short-term than OSTX.

Price Growth

CADL (@Biotechnology) experienced а -1.34% price change this week, while OSTX (@Biotechnology) price change was -7.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

CADL is expected to report earnings on Mar 26, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CADL($276M) has a higher market cap than OSTX($60.2M). CADL YTD gains are higher at: -49.194 vs. OSTX (-61.145). OSTX has higher annual earnings (EBITDA): -13.72M vs. CADL (-19.74M). CADL has more cash in the bank: 101M vs. OSTX (2.8M). CADL has less debt than OSTX: CADL (8.34M) vs OSTX (16.7M). CADL (0) and OSTX (0) have equivalent revenues.
CADLOSTXCADL / OSTX
Capitalization276M60.2M458%
EBITDA-19.74M-13.72M144%
Gain YTD-49.194-61.14580%
P/E RatioN/AN/A-
Revenue00-
Total Cash101M2.8M3,605%
Total Debt8.34M16.7M50%
TECHNICAL ANALYSIS
Technical Analysis
CADLOSTX
RSI
ODDS (%)
Bullish Trend 6 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 6 days ago
86%
Bearish Trend 6 days ago
90%
Momentum
ODDS (%)
Bullish Trend 6 days ago
85%
Bearish Trend 6 days ago
88%
MACD
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 6 days ago
70%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
84%
Bullish Trend 6 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 6 days ago
87%
Advances
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 8 days ago
82%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
89%
Bullish Trend 6 days ago
90%
Aroon
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CADL
Daily Signal:
Gain/Loss:
OSTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AEGXF19.47N/A
N/A
Aecon Group Inc.
ASXSF0.34N/A
N/A
Elysee Development Corp.
CHBH50.34N/A
N/A
Croghan Bancshares, Inc.
NIPNF39.27N/A
N/A
NEC Corp.
SPXSF90.10N/A
N/A
SPIRAX GROUP PLC

CADL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CADL has been loosely correlated with CYYNF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CADL jumps, then CYYNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CADL
1D Price
Change %
CADL100%
-1.56%
CYYNF - CADL
46%
Loosely correlated
N/A
RPTX - CADL
44%
Loosely correlated
-0.14%
OSTX - CADL
36%
Loosely correlated
-2.75%
MDGL - CADL
33%
Poorly correlated
-1.10%
KRRO - CADL
31%
Poorly correlated
-0.93%
More

OSTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, OSTX has been loosely correlated with CADL. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if OSTX jumps, then CADL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OSTX
1D Price
Change %
OSTX100%
-2.75%
CADL - OSTX
36%
Loosely correlated
-1.56%
RPTX - OSTX
34%
Loosely correlated
-0.14%
MRKR - OSTX
31%
Poorly correlated
+0.85%
PVLA - OSTX
28%
Poorly correlated
-3.19%
BOLD - OSTX
26%
Poorly correlated
-0.92%
More